DePuy Hip Implants Recalled Due To High Revision Rates.

Johnson & Johnson failed to take action on failing DePuy hip implants

June 10th, 2014

Nearly 100,000 patients who received a DePuy ASR hip replacement device were victims of the device manufacturer failing to take action, according to an investigative report by the Australian Broadcasting Corporation. According to the report, employees within Johnson & Johnson, the parent company of manufacturer DePuy Orthopaedics, admitted the implants were faulty.

Johnson & Johnson issued a DePuy recall in 2010 after studies found that the hip implants were failing at a high rate. DePuy hip side effects include tissue damage, limited mobility and toxic levels of metal in the bloodstream. Many DePuy complications often require revision surgery to correct.

Johnson & Johnson is now facing thousands of DePuy ASR hip replacement lawsuits alleging that the company released a defective device. Several other metal-on-metal hip replacement manufacturers have since issued recalls and metal hip implant side effects become an increasing concern in the medical community.

Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields